Successful Early Rescue with Isatuximab Plus Carfilzomib-Dexamethasone (ISA-KD) in Daratumumab-Refractory Newly Diagnosed Multiple Myeloma (NDMM) Patients with “No Washout Period”: A Real-World Clinical Experience in A Case Series and Literature Review. acmcr [Internet]. 2026 Jan. 9 [cited 2026 Sep. 11];10(1):1-5. Available from: https://fortunejournals.org/ojs/index.php/acmcr/article/view/23020